Pfizer raises full-year guidance after third-quarter profits beat expectations
FROM THE WIRE · FINANCE.YAHOO.COM
This article first appeared on GuruFocus. Pfizer Inc. (PFE, Financials) boosted its full-year guidance as third-quarter profits beat expectations, helped by newer drugs and cost cuts.Revenue was $16.6 billion, while adjusted profits were $0.87 per share. The firm recorded an…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishRaised guidance from a large pharmaceutical company is relevant for the sector and the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Pfizer raised its full-year guidance because third-quarter profits beat expectations.
- 02Revenue was 16.6 billion dollars and adjusted profit was 0.87 dollars per share.
- 03The 2026 forecast calls for sales of 62 to 64 billion dollars and adjusted EPS of 2.95 to 3.05 dollars.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets